Literature DB >> 27153277

Open-source guideseq software for analysis of GUIDE-seq data.

Shengdar Q Tsai1,2,3,4, Ved V Topkar1,2,3, J Keith Joung1,2,3,4, Martin J Aryee1,2,4,5.   

Abstract

Mesh：

Year:  2016        PMID： 27153277     DOI： 10.1038/nbt.3534

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases.

Authors:  Shengdar Q Tsai; Zongli Zheng; Nhu T Nguyen; Matthew Liebers; Ved V Topkar; Vishal Thapar; Nicolas Wyvekens; Cyd Khayter; A John Iafrate; Long P Le; Martin J Aryee; J Keith Joung
Journal:  Nat Biotechnol       Date:  2014-12-16       Impact factor: 54.908
  1 in total
  28 in total

1.  Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cells.

Authors:  Rafet Basar; May Daher; Nadima Uprety; Elif Gokdemir; Abdullah Alsuliman; Emily Ensley; Gonca Ozcan; Mayela Mendt; Mayra Hernandez Sanabria; Lucila Nassif Kerbauy; Ana Karen Nunez Cortes; Li Li; Pinaki P Banerjee; Luis Muniz-Feliciano; Sunil Acharya; Natalie W Fowlkes; Junjun Lu; Sufang Li; Stephan Mielke; Mecit Kaplan; Vandana Nandivada; Mustafa Bdaiwi; Alexander D Kontoyiannis; Ye Li; Enli Liu; Sonny Ang; David Marin; Lorenzo Brunetti; Michael C Gundry; Rolf Turk; Mollie S Schubert; Garrett R Rettig; Matthew S McNeill; Gavin Kurgan; Mark A Behlke; Richard Champlin; Elizabeth J Shpall; Katayoun Rezvani
Journal:  Blood Adv       Date:  2020-07-28

2.  Meganuclease targeting of PCSK9 in macaque liver leads to stable reduction in serum cholesterol.

Authors:  Lili Wang; Jeff Smith; Camilo Breton; Peter Clark; Jia Zhang; Lei Ying; Yan Che; Janel Lape; Peter Bell; Roberto Calcedo; Elizabeth L Buza; Alexei Saveliev; Victor V Bartsevich; Zhenning He; John White; Mingyao Li; Derek Jantz; James M Wilson
Journal:  Nat Biotechnol       Date:  2018-07-09       Impact factor: 54.908

3.  The fourth annual BRDS on genome editing and silencing for precision medicines.

Authors:  Amit Kumar Chaudhary; Rajan Sharma Bhattarai; Ram I Mahato
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

Review 4.  CRISPR-Cas9 genome engineering: Treating inherited retinal degeneration.

Authors:  Erin R Burnight; Joseph C Giacalone; Jessica A Cooke; Jessica R Thompson; Laura R Bohrer; Kathleen R Chirco; Arlene V Drack; John H Fingert; Kristan S Worthington; Luke A Wiley; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Prog Retin Eye Res       Date:  2018-03-22       Impact factor: 21.198

5.  Editing a γ-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype.

Authors:  Leslie Weber; Giacomo Frati; Tristan Felix; Giulia Hardouin; Antonio Casini; Clara Wollenschlaeger; Vasco Meneghini; Cecile Masson; Anne De Cian; Anne Chalumeau; Fulvio Mavilio; Mario Amendola; Isabelle Andre-Schmutz; Anna Cereseto; Wassim El Nemer; Jean-Paul Concordet; Carine Giovannangeli; Marina Cavazzana; Annarita Miccio
Journal:  Sci Adv       Date:  2020-02-12       Impact factor: 14.136

Review 6.  Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases.

Authors:  Shengdar Q Tsai; J Keith Joung
Journal:  Nat Rev Genet       Date:  2016-05       Impact factor: 53.242

7.  Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells.

Authors:  Giulia Pavani; Anna Fabiano; Marine Laurent; Fatima Amor; Erika Cantelli; Anne Chalumeau; Giulia Maule; Alexandra Tachtsidi; Jean-Paul Concordet; Anna Cereseto; Fulvio Mavilio; Giuliana Ferrari; Annarita Miccio; Mario Amendola
Journal:  Blood Adv       Date:  2021-03-09

Review 8.  Defining genome-wide CRISPR-Cas genome-editing nuclease activity with GUIDE-seq.

Authors:  Nikolay L Malinin; GaHyun Lee; Cicera R Lazzarotto; Yichao Li; Zongli Zheng; Nhu T Nguyen; Matthew Liebers; Ved V Topkar; A John Iafrate; Long P Le; Martin J Aryee; J Keith Joung; Shengdar Q Tsai
Journal:  Nat Protoc       Date:  2021-11-12       Impact factor: 17.021

9.  Prediction of off-target activities for the end-to-end design of CRISPR guide RNAs.

Authors:  Jennifer Listgarten; Michael Weinstein; Benjamin P Kleinstiver; Alexander A Sousa; J Keith Joung; Jake Crawford; Kevin Gao; Luong Hoang; Melih Elibol; John G Doench; Nicolo Fusi
Journal:  Nat Biomed Eng       Date:  2018-01-10       Impact factor: 25.671

10.  Tag-seq: a convenient and scalable method for genome-wide specificity assessment of CRISPR/Cas nucleases.

Authors:  Hongxin Huang; Yongfei Hu; Guanjie Huang; Shufeng Ma; Jianqi Feng; Dong Wang; Ying Lin; Jiajian Zhou; Zhili Rong
Journal:  Commun Biol       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.